【問題】APPRAISE 2 ?推薦回答
關於「APPRAISE 2」標籤,搜尋引擎有相關的訊息討論:
Phase III Acute Coronary Syndrome - Full Text View - ClinicalTrials ...。
Phase III Acute Coronary Syndrome (APPRAISE-2). The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.: 。
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 ...。
2013年10月3日 · Background To assess potentially elevated cardiovascular risk related to new antihyperglycemic drugs in patients with type 2 diabetes, ...: tw | tw。
Apixaban for Prevention of Acute Ischemic Events 2 - APPRAISE-2。
2015年8月14日 · The phase II APPRAISE-1 trial noted that in patients with recent acute coronary syndrome (ACS), apixaban, in the background of dual ...: 。
Apixaban following acute coronary syndromes in patients with prior ...。
Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial. Am Heart J. 2018 Mar;197:1-8. doi: ...: 。
2014 AHA/ACC Guideline for the Management of Patients With Non ...。
2014年9月23日 · In response to published reports from the Institute of Medicine and the ACC/AHA's mandate to evaluate new knowledge and maintain relevance at ...。
2015 ESC Guidelines for the management of acute coronary。
The Apixaban for Prevention of Acute Ischaemic Events (APPRAISE) 2 study assessed the ... GL . The CT-STAT (coronary computed tomographic angiography for ...。
2017 ESC focused update on dual antiplatelet therapy in coronary ...。
Hazard ratio. I-LOVE-IT 2. Evaluate Safety and Effectiveness of the Tivoli DES and the Firebird DES for Treatment of Coronary Revascularization.。
Telephone Directory。
... Acoustic Sys ( JP - 2 ) CAPT G L Jones 602 ( PMA - 264 ) - 27134 Dep Proj Mgr CDR J A Messegee ( 264A ) - 27134 Dep for Current Sys H E Goldstein ---- .。
Publications of the Geological Survey。
Map showing appraisal of oil and gas potential of RARE II proposed roadless areas in National forest , COLORADO , by C. W. Spencer and G. L. Dolton .。
[PDF] Appraisal Tools for Clinical Practice Guidelines: A ... - PLOS。
Editor: Yu-Kang Tu, National Taiwan University, Taiwan. Received July 5, 2013; ... 2, better 4 yes / yes yes no. APWCA 2010 [81]. EN. n. s. no yes. GL.
常見APPRAISE 2問答
延伸文章資訊The ATLAS ACS 2–TIMI 51 Trial and the Burden of Missing Data: (Anti-Xa Therapy to Lower Cardiovas...
... (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial ... Three patients in stratum...
In this double-blind, placebo-controlled trial, we randomly assigned 15,526 patients with a recen...
These percentages differ greatly from the ATLAS ACS‐2 TIMI 51 trial at large (24% unstable angina...
ATLAS ACS 2-TIMI 51 was a phase III, multicenter, randomized, double-blind, placebo-controlled cl...
The phase II ATLAS ACS–TIMI 46 trial noted that in patients with recent acute coronary syndrome (...
Design · Multicenter, double-blind, parallel group, randomized, placebo-controlled trial · N=15,3...
Objectives and methods:: ATLAS ACS 2-TIMI 51 was a double-blind, placebo-controlled clinical tria...
The ATLAS ACS 2–TIMI 51 Trial and the Burden of Missing Data: (Anti-Xa Therapy to Lower Cardiovas...
... (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial ... Three patients in stratum...
In this double-blind, placebo-controlled trial, we randomly assigned 15,526 patients with a recen...
These percentages differ greatly from the ATLAS ACS‐2 TIMI 51 trial at large (24% unstable angina...
ATLAS ACS 2-TIMI 51 was a phase III, multicenter, randomized, double-blind, placebo-controlled cl...
The phase II ATLAS ACS–TIMI 46 trial noted that in patients with recent acute coronary syndrome (...
Design · Multicenter, double-blind, parallel group, randomized, placebo-controlled trial · N=15,3...
Objectives and methods:: ATLAS ACS 2-TIMI 51 was a double-blind, placebo-controlled clinical tria...